← Back to Awards
NIHNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Task A: Early Phase Clinical Trial Units (EPCTU)
- Institution
- DYNPORT VACCINE COMPANY, LLC, MD
- Principal investigator
- George Saviolakis
- Funding
- $216K
- Duration
- 2022–2026
Moonbase score
Still being scored
Abstract
The Early Phase Clinical Trial Units provide a vehicle for investigation of new agents in the treatment and prevention of infectious diseases and can carry out all aspects of interventional clinical trial implementation.
LOADING MOONBASE SCORE
Questions for Dynport Vaccine Company, Llc
Dynport Vaccine Company, Llc hasn't set up its Moonbase portfolio yet, so questions about this research can't be asked here.
Related grants
Same topic, scored first.
- NIH · Ppd Development LPNot yet scored
Task A: Early Phase Clinical Trial Units (EPCTU)
Sandra Palleja · $183K · 2022–2026
- NIH · Allucent Government Services (US) LlcNot yet scored
Early Phase Clinical Trial Units (EPCTU)
Kelly Mckee · $144K · 2022–2026
- NIH · Duke UniversityNot yet scored
Early Phase Clinical Trial Units (EPCTU)
Susanna Naggie · $193K · 2022–2026